The rise in haematological disorders, as well as the ability to diagnose a number of diseases and illnesses through blood sample testing, has led to a growing demand for high-performance laboratories. This refers to commercial service providers and hospital laboratories that need to simplify the whole workflow to test as many samples as possible, contributing to a rise in the haematology analyser and reagent market. Haematology analysers and reagents are expected to experience high demand during the COVID-19 pandemic owing to its ability to sort virus-infected patients on the basis of blood parameters, including viscosity.